Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy
Reference47 articles.
1. World Health Organization. Pharmacovigilance: Ensuring the safe use of medicines. http://www.who-umc.org/graphics/24753.pdf. Accessed Nov 2015.
2. Campbell J, Gossell-Williams M, Lee M. A review of pharmacovigilance. West Indian Med J. 2014;63(7):771–4.
3. Van Grootheest K. The dawn of pharmacovigilance: an historical perspective. Int J Pharm Med. 2003;. https://doi.org/10.2165/00124363-200317050-00006.
4. Saito M, Hirata-Koizumi M, Miyake S, Hasegawa R. Withdrawal of cerivastatin revealed a flaw of post-marketing surveillance system in the United States. Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku. 2005;123:41–5.
5. Dieppe PA, Ebrahim S, Martin RM, Jüni P. Lessons from the withdrawal of rofecoxib. BMJ. 2004;329(7471):867–8.
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献